Abstract
Information regarding the characteristics and health of women who do and do not attend for breast cancer screening is limited and representative data are difficult to obtain. Information on age, deprivation and prescriptions for various medications was obtained for all women at two UK general practices who were invited to breast cancer screening through the National Health Service Breast Screening Programme. The characteristics of women who attended and did not attend screening were compared. Of the 1064 women invited to screening from the two practices, 882 (83%) attended screening. Screening attenders were of a similar age to non-attenders but came from significantly less deprived areas (30% of attenders versus 50% of non-attenders came from the most deprived areas, P < 0.0001) and were more likely to have a current prescription for hormone replacement therapy (32% versus 19%, P < 0.0001). No significant differences in recent prescriptions of medication for hypertension, heart disease, hypercholesterolaemia, diabetes mellitus, asthma, thyroid disease or depression/anxiety were observed between attenders and non-attenders. Women who attend the National Health Service Breast Screening Programme come from less deprived areas and are more likely to have a current prescription for hormone replacement therapy than non-attenders, but do not differ in terms of age or recent prescriptions for various other medications.
MeSH Terms
Age Factors
Breast Neoplasms/diagnostic imaging,prevention & control,psychology
England
Family Practice
Female
Hormone Replacement Therapy/statistics & numerical data
Humans
Mammography/statistics & numerical data
Middle Aged
Patient Acceptance of Health Care
Prospective Studies
Rural Health
Socioeconomic Factors
Urban Health
Women's Health
Authors & Affiliations
12 authors, click to expand affiliations / ORCID
Banks Emily
Imperial Cancer Research Fund Cancer Epidemiology Unit, University of Oxford, Radcliffe Infirmary, Oxford, UK. bankse@icrf.icnet.uk
Beral Valerie
Cameron Rebecca
Hogg Ann
Langley Nicola
Barnes Isobel
Bull Diana
Reeves Gillian
English Ruth
Taylor Sarah
Elliman Jon
Lole Harris Carole
References (15)
15 references, click to expand
-
Predictors of non-attendance in a population-based mammography screening programme; socio-demographic factors and aspects of health behaviour.
Eur J Cancer Prev. 2000 Feb;9(1):25-33
PMID: 10777007
-
Psychosocial predictors of first attendance for organised mammography screening.
J Med Screen. 1999;6(2):82-8
PMID: 10444726
-
Agreement between general practice prescription data and self-reported use of hormone replacement therapy and treatment for various illnesses.
J Epidemiol Biostat. 2001;6(4):357-63
PMID: 12036270
-
Patterns and determinants of conjugated estrogen use.
Am J Epidemiol. 1979 Jun;109(6):676-86
PMID: 222140
-
Women who decline breast screening.
J Epidemiol Community Health. 1984 Dec;38(4):278-83
PMID: 6512479
-
Attenders and non-attenders at a breast screening clinic: a comparative study.
Public Health. 1988 Jan;102(1):3-10
PMID: 3344310
-
Participation in breast screening programs: a review.
Soc Sci Med. 1990;30(10):1107-18
PMID: 2194294
-
Demographic predictors of mammography and Pap smear screening in US women.
Am J Public Health. 1993 Jan;83(1):53-60
PMID: 8417607
-
Prospective study of predictors of attendance for breast screening in inner London.
J Epidemiol Community Health. 1994 Feb;48(1):65-73
PMID: 8138773
-
Recruitment activities and sociodemographic factors that predict attendance at a mammographic screening program.
Am J Public Health. 1994 Oct;84(10):1655-8
PMID: 7943490
-
A prospective cohort study investigating psychosocial predictors of attendance at a mobile breast screening service.
Aust J Public Health. 1995 Apr;19(2):172-6
PMID: 7786944
-
Hormone replacement therapy: characteristics of users and non-users in a British general practice cohort identified through computerised prescribing records.
J Epidemiol Community Health. 1995 Aug;49(4):389-94
PMID: 7650462
-
Encouraging attendance at a screening mammography programme: determinants of response to different recruitment strategies.
J Med Screen. 1994 Jul;1(3):144-9
PMID: 8790507
-
Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer.
Lancet. 1997 Oct 11;350(9084):1047-59
PMID: 10213546
-
The Million Women Study: design and characteristics of the study population. The Million Women Study Collaborative Group.
Breast Cancer Res. 1999;1(1):73-80
PMID: 11056681